BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2132377)

  • 1. [An analysis of the effect of measles vaccination program by a mathematical model].
    Kakehashi M
    Nihon Koshu Eisei Zasshi; 1990 Jul; 37(7):481-90. PubMed ID: 2132377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulse vaccination strategy in the SIR epidemic model.
    Shulgin B; Stone L; Agur Z
    Bull Math Biol; 1998 Nov; 60(6):1123-48. PubMed ID: 9866452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measles epidemiology in the Netherlands: a exploratory analysis of notification].
    Wallinga J; van den Hof S
    Ned Tijdschr Geneeskd; 2000 Jan; 144(4):171-4. PubMed ID: 10668543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The strategy for prevention of measles and rubella prevalence with measles-rubella (MR) vaccine in Japan.
    Ihara T
    Vaccine; 2009 May; 27(24):3234-6. PubMed ID: 19366578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles vaccination during the respiratory virus season and risk of vaccine failure.
    Edmonson MB; Davis JP; Hopfensperger DJ; Berg JL; Payton LA
    Pediatrics; 1996 Nov; 98(5):905-10. PubMed ID: 8909484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal screening and postpartum vaccination for measles infection in Japan: a cohort study.
    Shoda A; Hayashi M; Takayama N; Oshima K; Nishikawa M; Okazaki T; Negishi M; Hayashida S; Watanabe H; Inaba N
    BJOG; 2011 Jan; 118(1):88-92. PubMed ID: 21197682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
    Ikić DM
    Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the eight-year period of compulsory measles vaccination in the Czech Socialist Republic (CSR).
    Sejda J
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):273-83. PubMed ID: 575149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measles in Norway. Epidemiology before and after the introduction of routine vaccination].
    Martin PR
    Tidsskr Nor Laegeforen; 1989 Oct; 109(29):2984-8. PubMed ID: 2588224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPI sentinel surveillance for Kwara, 1982-1987.
    Babaniyi O
    West Afr J Med; 1993; 12(4):218-22. PubMed ID: 8199064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
    Ong G; Hoon HB; Ong A; Chua LT; Kai CS; Tai GK
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):96-101. PubMed ID: 16771219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles eradication in the Americas: progress to date.
    de Quadros CA; Izurieta H; Venczel L; Carrasco P
    J Infect Dis; 2004 May; 189 Suppl 1():S227-35. PubMed ID: 15106116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the impact of the HIV pandemic on measles control and elimination.
    Helfand RF; Moss WJ; Harpaz R; Scott S; Cutts F
    Bull World Health Organ; 2005 May; 83(5):329-37. PubMed ID: 15976873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001.
    Munyoro MN; Kufa E; Biellik R; Pazvakavambwa IE; Cairns KL
    J Infect Dis; 2003 May; 187 Suppl 1():S91-6. PubMed ID: 12721898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.